As interest in therapeutic TIDES grows, regulatory agencies are increasingly requiring more rigorous characterization to ensure patient safety, drug efficacy, and quality. To meet these demands, ...
At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and automation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results